Q32 Bio (QTTB) Assets Average (2018 - 2026)

Q32 Bio has reported Assets Average for 9 years, with the latest figure at $62.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 26.81% year-over-year to $62.7 million; the trailing twelve-month figure through Mar 2026 stood at $62.7 million (down 26.81% YoY), and the FY2025 full-year result was $77.1 million, up 10.56% from the prior year.
• Assets Average for Q1 2026 stood at $62.7 million, up from $59.8 million in the prior quarter.
• The five-year high for Assets Average was $297.8 million in Q2 2022, with the low at $59.8 million in Q4 2025.
• Average Assets Average over 5 years is $148.1 million, with a median of $114.4 million recorded in 2024.
• Year-over-year, Assets Average advanced 20.65% in 2022 and tumbled 61.9% in 2023.
• Tracing QTTB's Assets Average over 5 years: stood at $245.6 million in 2022, then plunged by 61.9% to $93.6 million in 2023, then gained by 5.21% to $98.4 million in 2024, then plunged by 39.27% to $59.8 million in 2025, then gained by 4.93% to $62.7 million in 2026.
• The last three Assets Average figures came in at $62.7 million (Q1 2026), $59.8 million (Q4 2025), and $62.0 million (Q3 2025), per Business Quant data.

Peer Comparison